Tyra Biosciences, Inc.
USD31.85
+0.80 (+2.56%)
CEO
Todd Harris
IPO Date
2021-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.07
Prev. Close
$31.05
Day Low
$31.07
Day High
$31.96
52W Low
$9.96
52W High
$40.65
Market Cap
$1.89B
Volume
0.34M
| 13,160 |
| $32.68 |
| 1 Jun 2026 | Moran Susan | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | Simson Jake | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | Gulfo Adele M. | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | MORE ROBERT J | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | Rothenberg Stephen Michael | director | A-Award | Acquired | 13,160 | $32.68 |
| 7 May 2026 | Warner Douglas J | Chief Medical Officer | A-Award | Acquired | 25,000 | $0.00 |
| 7 May 2026 | Warner Douglas J | Chief Medical Officer | A-Award | Acquired | 85,000 | $33.93 |
| 7 May 2026 | Fuhrman Alan | Chief Financial Officer | A-Award | Acquired | 20,000 | $0.00 |